82 results
8-K
EX-10.2
ADAP
Adaptimmune Therapeutics Plc
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
subject to awards which (in whole or in part) have lapsed or otherwise become incapable of exercise (other than by reason of the satisfaction thereof … to the satisfaction of the Board);
redundancy (within the meaning of the Employment Rights Act 1996);
Page 15
the Option Holder’s Employer ceasing
8-K
EX-10.1
ekvsrgfucym1 11i
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
EX-10.1
5nawhlqc6keyr7def
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
425
0wxcqr
30 May 23
Business combination disclosure
4:21pm
8-K
xgipq
30 May 23
Submission of Matters to a Vote of Security Holders
4:18pm
425
l6am xhgon
22 May 23
Business combination disclosure
7:01am
8-K
7fl630
22 May 23
Other Events
6:59am
8-K
EX-99.1
iq2uhgd7zl itpnfn
12 May 23
Adaptimmune Reports First Quarter Financial Results and Business Update
7:36am
424B3
32opjnazn2
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
bjnufm
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
exm2o6ns dkk9u6
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm